Our work is the clinical validation of a deep-learning algorithm (DLR) used to denoise MR images on quantitative MR biomarkers. Since it has been trained on including T1- and T2-weighted conventional images, in healthy volunteers, its effects on multiparametric quantitative MRI in patients, are uncertain. It could potentially improve brain tumors characterization by providing quantitative biomarkers under clinical time-constraints.
No takes yet. Share an insight, caveat, or question.
Debacker et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: